141 related articles for article (PubMed ID: 25756394)
1. TGFβ-induced phosphorylation of Par6 promotes migration and invasion in prostate cancer cells.
Mu Y; Zang G; Engström U; Busch C; Landström M
Br J Cancer; 2015 Mar; 112(7):1223-31. PubMed ID: 25756394
[TBL] [Abstract][Full Text] [Related]
2. Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor β-induced epithelial-to-mesenchymal transition.
Gunaratne A; Thai BL; Di Guglielmo GM
Mol Cell Biol; 2013 Mar; 33(5):874-86. PubMed ID: 23249950
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast-derived factors promote metastatic potential in human prostate cancer cells, in part via non-canonical transforming growth factor β (TGFβ) signaling.
Karlsson T; Sundar R; Widmark A; Landström M; Persson E
Prostate; 2018 May; 78(6):446-456. PubMed ID: 29383751
[TBL] [Abstract][Full Text] [Related]
4. Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.
Zhang K; Zhao H; Ji Z; Zhang C; Zhou P; Wang L; Chen Q; Wang J; Zhang P; Chen Z; Zhu HH; Gao WQ
Oncogene; 2016 Mar; 35(10):1271-82. PubMed ID: 26050620
[TBL] [Abstract][Full Text] [Related]
5. Par6 is phosphorylated by aPKC to facilitate EMT.
Gunaratne A; Di Guglielmo GM
Cell Adh Migr; 2013; 7(4):357-61. PubMed ID: 23880940
[TBL] [Abstract][Full Text] [Related]
6. TGFβ-induced invasion of prostate cancer cells is promoted by c-Jun-dependent transcriptional activation of Snail1.
Thakur N; Gudey SK; Marcusson A; Fu JY; Bergh A; Heldin CH; Landström M
Cell Cycle; 2014; 13(15):2400-14. PubMed ID: 25483191
[TBL] [Abstract][Full Text] [Related]
7. Roles of partitioning-defective protein 6 (Par6) and its complexes in the proliferation, migration and invasion of cancer cells.
Ruan L; Shen Y; Lu Z; Shang D; Zhao Z; Lu Y; Wu Y; Zhang Y; Tu Z; Liu H
Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):909-913. PubMed ID: 28590507
[TBL] [Abstract][Full Text] [Related]
8. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
[TBL] [Abstract][Full Text] [Related]
9. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
10. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer.
Nolan ME; Aranda V; Lee S; Lakshmi B; Basu S; Allred DC; Muthuswamy SK
Cancer Res; 2008 Oct; 68(20):8201-9. PubMed ID: 18922891
[TBL] [Abstract][Full Text] [Related]
11. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
[TBL] [Abstract][Full Text] [Related]
12. TGFβ and BMP-2 regulate epicardial cell invasion via TGFβR3 activation of the Par6/Smurf1/RhoA pathway.
Sánchez NS; Barnett JV
Cell Signal; 2012 Feb; 24(2):539-548. PubMed ID: 22033038
[TBL] [Abstract][Full Text] [Related]
13. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
14. TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression.
Sun Y; Schaar A; Sukumaran P; Dhasarathy A; Singh BB
Mol Carcinog; 2018 Jun; 57(6):752-761. PubMed ID: 29500887
[TBL] [Abstract][Full Text] [Related]
15. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Xu L; Chen S; Bergan RC
Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
[TBL] [Abstract][Full Text] [Related]
16. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
[TBL] [Abstract][Full Text] [Related]
17. The TGFbeta-Par6 polarity pathway: linking the Par complex to EMT and breast cancer progression.
Viloria-Petit AM; Wrana JL
Cell Cycle; 2010 Feb; 9(4):623-4. PubMed ID: 20107326
[No Abstract] [Full Text] [Related]
18. [Influence of phosphoprotein associated with glycosphingolipid microdomains 1 on biologic behavior of human prostatic cancer cell line in-vitro].
Yu WJ; Wang YW; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):615-20. PubMed ID: 21092590
[TBL] [Abstract][Full Text] [Related]
19. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
[TBL] [Abstract][Full Text] [Related]
20. aPKC alters the TGFβ response in NSCLC cells through both Smad-dependent and Smad-independent pathways.
Gunaratne A; Chan E; El-Chabib TH; Carter D; Di Guglielmo GM
J Cell Sci; 2015 Feb; 128(3):487–98. PubMed ID: 25501807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
